Clareo Health | Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Indiana Kidney Stone Institute
With
University of Washington
VA Puget Sound Health Care System
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Scheduled to undergo surgery (URS or PCNL) for a primary stone.
Computed tomography (CT) exam within the 90-day pre-operative period
Small (≤ 6mm) asymptomatic stones in visible on KUB or CT (i.e., calcium stones) in the contralateral kidney for a primary renal stone or ipsilateral kidney for primary ureteral stone.
Recurrent (having had previous stones) or multiple (simultaneous bilateral stones) stones
Able to give informed consent
Age 21 years or older
You may not be if
Inability to give informed consent
Age less than 21 years
Stones not visible on KUB or CT
Patients with systemic disease or renal anatomical disorders (RTA, primary hyperparathyroidism, sarcoidosis, enteric hyperoxaluria, medullary sponge kidney)
Any condition (eg, psychiatric illness) or situation that, in the investigator's opinion, could put the
subject at significant risk, confound the study results, or interfere significantly with the subject's
